Fierce Pharma

Amgen's Humira Biosimilar is a biologic medication used to treat a variety of autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis. It works by blocking the action of certain proteins in the body that cause inflammation. This biosimilar is designed to provide the same efficacy and safety as the original Humira, but at a lower cost. It is administered via subcutaneous injection and is available in both prefilled syringes and pens.

Menarini Big Pharma SERD is a revolutionary new drug developed by Menarini, one of the world's leading pharmaceutical companies. It is designed to treat advanced breast cancer and has been shown to be effective in clinical trials. The drug works by targeting a specific protein that is involved in the growth and spread of cancer cells. It is administered intravenously and has been found to be well tolerated with minimal side effects. This innovative treatment offers hope to those suffering from advanced breast cancer and could potentially save lives.